
Cambridge Capital Group
Description
Cambridge Capital Group (CCG) stands as a prominent angel network and seed fund based in Cambridge, United Kingdom, playing a crucial role in the region's vibrant tech and life sciences ecosystem. Established in 2000, CCG specializes in connecting high-net-worth individuals and private venture funds with ambitious early-stage companies, primarily within the high-tech, deep tech, and life sciences sectors. Their focus is on nurturing innovative ventures from their nascent stages, providing not only capital but also strategic guidance and access to a vast network of experienced professionals.
CCG typically participates in investment rounds ranging from approximately $190,500 to $1,905,000, with the average round size often around $952,500 (converted from £750,000). This flexibility allows them to support a diverse range of early-stage funding needs. The group operates by syndicating deals, leveraging its extensive network of over 100 active angel investors. They frequently co-invest with other venture capital firms and institutional investors, enabling larger funding rounds and providing companies with broader access to follow-on capital and expertise.
Since its inception, Cambridge Capital Group has demonstrated a significant impact on the UK's startup landscape. The group has successfully helped over 100 companies raise more than $127 million in total capital. This substantial financial backing underscores their commitment to fostering innovation and economic growth within the Cambridge cluster and beyond. Their track record includes numerous successful exits and follow-on funding rounds for their portfolio companies, solidifying their reputation as a key player in early-stage venture investment.
Investor Profile
Cambridge Capital Group has backed more than 44 startups, with 1 new investments in the last 12 months alone. The firm has led 4 rounds, about 9% of its total and boasts 8 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series Unknown rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States.
- Strong thematic focus on Software, Biotechnology, Artificial Intelligence (AI).
- Typical check size: $190.5K – $1.9M.
Stage Focus
- Seed (36%)
- Series A (20%)
- Series Unknown (20%)
- Series B (9%)
- Angel (7%)
- Series C (7%)
Country Focus
- United Kingdom (95%)
- United States (5%)
Industry Focus
- Software
- Biotechnology
- Artificial Intelligence (Ai)
- Health Care
- Web Development
- Hardware
- Medical
- Machine Learning
- Developer Platform
- E-commerce
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.